Freakonomics Radio cover image

Extra: Why Is 23andMe Going Under? (Update)

Freakonomics Radio

00:00

The Rise and Fall of 23andMe

This chapter explores the trajectory of 23andMe, highlighting its initial success and subsequent struggles in the competitive genetics market. It examines key challenges such as monetizing wellness products, the impact of a recent data breach, and the company's pivot towards private ownership amidst financial pressures. The discussion underscores the potential of 23andMe's data while questioning the feasibility of its business model and future innovation in drug discovery.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app